Advised on the sale of BluVet to Ca’ Zampa

Vitale (IMAP Italy) advised NB Aurora and F&P in the disposal of BluVet to Ca’ Zampa, an integrated platform of veterinary clinics, with the simultaneous reinvestment from NB Aurora only, alongside Nextalia, in the new group to support its further development.

Founded in 2019, BluVet is an Italian platform aimed at consolidating the domestic market of medium to large veterinary clinics through M&A activities. The initiative was sponsored by Aurora, alongside established managers with many years of industry experience and a strong network in the Italian veterinary sector. Since its inception, the company has completed over 25 acquisitions of veterinary clinics, achieving a total turnover of approximately €33m in 2023.

Ca’ Zampa is an Italian hub of around 20 veterinary facilities that has grown both through the opening of new greenfield facilities and the acquisition of existing clinics, working on a project to strongly integrate its network. The Ca’ Zampa Group is backed by Italian entrepreneurs and investors as well as the G Square Capital fund and is among the leading players in the Italian market.

At the same time as the sale was completed, Aurora, together with its co-investment funds, reinvested in Ca’ Zampa alongside Nextalia, as part of a broader capital increase transaction, as a result of which it will hold a minority stake. F&P Equity Partners will not be part of the new group.